An Epidemic of Mucormycosis Coinciding With the COVID-19 Pandemic in India

ArunSundar MohanaSundaram, MPharm, PhD1, Shanmugarajan Thukani Sathanantham, MPharm, PhD2, Abhijit Kulkarni, MS, MCh3, 4, 5, Shweta Kulkarni, DOMS, FCPS6, Vijay Chinchole, MD, DPM, MIPS7, 8, 9, Bhushan Patil, MD, MIPS8, 9, Ravichandiran Velayutham, MPharm, PhD10

1School of Pharmacy, Sathyabama Institute of Science and Technology, Chennai, India

2School of Pharmaceutical Sciences, Vels Institute of Science, Technology & Advanced Studies, Chennai, India

3Apollo Hospital, Navi Mumbai, India

4SRV Mamata Hospital, Dombivli, India

5Aditya Brain and Spine Clinic, Dombivli, India

6Vedh Eye Hospital, Dombivli, India

7Manobal Neuropsychiatric Clinic, Dombivli, India

8MannSparsh Neuropsychiatric Hospital, Kalyan, India

9Manasa Rehabilitation & De-Addiction Center, Titwala, India

10National Institute of Pharmaceutical Education and Research, Kolkata, India


Corresponding Author:

ArunSundar MohanaSundaram, School of Pharmacy, Sathyabama Institute of Science and Technology, Jeppiaar Nagar, Rajiv Gandhi Salai, Chennai 600 119, India. Email:

View original article
ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH

留言 (0)

沒有登入
gif
format_indent_decrease